Clinical data have demonstrated that a single 10‐g dose of SZC resulted in a rapid and significant reduction in sK+ as early as 1 hour after administration, suggesting that SZC may serve as an adjunct therapy to insulin and glucose in the emergency treatment of hyperkalemia.23 This evidence concerns the gene INS and Hyperkalemia.